Defense Health Agency Contracting Activity - DHACA

Description

The intent of the FY19 ERP IDA is to solicit novel, innovative research to understand the magnitude and underlying mechanisms of PTE related to the ERP’s mission (see Section II.A, Program Description). The work should innovatively challenge existing research paradigms or exhibit high levels of creativity within the contexts of the ERP’s mission and vision. The research innovations for the FY19 ERP IDA are expected to benefit the military, Veteran, and civilian communities. Applications should be both innovation- and impact-based. The FY19 ERP IDA offers two levels of funding. Funding Level I is intended to support high-risk and/or high-gain applications with named Principal Investigators (PIs) at or above the level of a postdoctoral fellow (or equivalent), but below the level of Assistant Professor (or equivalent). Note that Funding Level I applications will be required to include an Eligibility Statement (Attachment 6) in order to verify the eligibility of the individual named as the PI for this award. Funding Level II is intended to support a more mature, hypothesis-driven research project. For an FY19 ERP IDA Funding Level II application, the PI must be an independent investigator at or above the level of Assistant Professor (or equivalent). Study teams are expected to demonstrate expertise in both TBI and epilepsy. While not required, applications to either Funding Level I or II are encouraged to provide relevant preliminary data. Preliminary data for either funding level may come from the PI’s published work, pilot data, or from peer-reviewed literature. The proposed research must be relevant to active duty Service members, Veterans, military beneficiaries, and the American public. The maximum period of performance is 3 years for both funding levels. For Funding Level I: The anticipated direct costs budgeted for the entire period of performance for a Funding Level I FY19 ERP IDA will not exceed $300,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. For Funding Level II: The anticipated direct costs budgeted for the entire period of performance for a Funding Level II FY19 ERP IDA will not exceed $500,000. Refer to Section II.D.5, Funding Restrictions, for detailed funding information. The requested budget level should be appropriate for the scope of research proposed. FY19 ERP IDA Focus Areas: The Focus Areas below are specific to the FY19 ERP IDA and should be carefully considered as part of the application process. • Innovative Research • Markers and Mechanisms • Epidemiology • Longitudinal Studies An application that proposes research outside of these FY19 ERP IDA Focus Areas is acceptable, as long as the applicant provides a strong rationale. These should be carefully considered as part of the application process. The CDMRP expects to allot approximately $1.0M to fund approximately two IDA Funding Level I applications and approximately $2.4M to fund approximately three IDA Funding Level II applications. Funding of applications received is contingent upon the availability of Federal funds for this program as well as the number of applications received, the quality and merit of the applications as evaluated by scientific and programmatic review, and the requirements of the Government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY19 funding opportunity will be funded with FY19 funds, which will expire for use on September 30, 2025. Awards will be made no later than September 30, 2020. For additional information refer to Section II.F.1, Federal Award Notices.

Who can apply

• Unrestricted

Contact

CDMRP Help Desk <br/>Phone: 301-682-5507 <br/>Email: help@eBRAP.org
help@eBRAP.org